Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 7.42%236.94M | -2.82%419.11M | -0.32%220.57M | 34.92%431.29M | 32.56%221.28M | -12.33%319.67M | -3.56%166.93M | 8.81%364.63M | 57.44%173.1M | -6.32%335.1M |
| Operating income | 7.42%236.94M | -2.82%419.11M | -0.32%220.57M | 34.92%431.29M | 32.56%221.28M | -12.33%319.67M | -3.56%166.93M | 8.81%364.63M | 57.44%173.1M | -6.32%335.1M |
| Cost of sales | -4.08%-166.25M | 6.99%-298.31M | 1.41%-159.73M | -10.59%-320.72M | -2.10%-162.02M | 11.56%-290.01M | -8.54%-158.69M | -18.24%-327.9M | -68.75%-146.21M | -7.53%-277.31M |
| Operating expenses | -4.08%-166.25M | 6.99%-298.31M | 1.41%-159.73M | -10.59%-320.72M | -2.10%-162.02M | 11.56%-290.01M | -8.54%-158.69M | -18.24%-327.9M | -68.75%-146.21M | -7.53%-277.31M |
| Gross profit | 16.19%70.69M | 9.26%120.81M | 2.67%60.84M | 272.75%110.57M | 619.44%59.26M | -19.25%29.66M | -69.37%8.24M | -36.44%36.73M | 15.38%26.89M | -42.10%57.79M |
| Selling expenses | -17.72%-7.38M | 0.86%-12.49M | -6.00%-6.27M | -27.86%-12.6M | -29.69%-5.92M | -0.92%-9.85M | 10.20%-4.56M | 1.79%-9.76M | 6.74%-5.08M | 34.94%-9.94M |
| Administrative expenses | -5.91%-39.29M | 17.72%-75.63M | 4.01%-37.1M | 15.04%-91.91M | 10.92%-38.65M | -79.53%-108.19M | 10.34%-43.39M | 47.25%-60.26M | -1.41%-48.39M | 16.21%-114.24M |
| Revaluation surplus | -146.71%-53M | -174.27%-78.05M | ---21.48M | ---28.46M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Changes in the fair value of investment property | -146.71%-53M | -174.27%-78.05M | ---21.48M | ---28.46M | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provision | -1,211.88%-6.74M | -99.56%1.68M | -99.45%606K | 737.08%384.79M | 144.74%110.06M | 103.48%45.97M | 369.98%44.97M | -7,203.89%-1.32B | 241.70%9.57M | 129.44%18.59M |
| -Impairment of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---12.98M | ---- | ---- | ---- | ---- |
| -Other impairment is provision | -1,211.88%-6.74M | -99.56%1.68M | -99.45%606K | 552.74%384.79M | 144.74%110.06M | 104.46%58.95M | 369.98%44.97M | -7,203.89%-1.32B | 241.70%9.57M | 129.44%18.59M |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -26.54%-3.12M |
| Special items of operating profit | 67.03%51.9M | -41.88%32.93M | 35.60%31.07M | 31.43%56.66M | -15.06%22.91M | -84.44%43.11M | -79.77%26.98M | -6.05%277.11M | -18.58%133.38M | -64.21%294.94M |
| Operating profit | -41.52%16.18M | -102.57%-10.75M | -81.26%27.67M | 59,508.96%419.05M | 358.05%147.68M | 100.07%703K | -72.29%32.24M | -541.28%-1.08B | -8.52%116.37M | -70.79%244.02M |
| Financing cost | 26.86%-531K | 62.53%-1.47M | 43.06%-726K | 19.91%-3.92M | 9.25%-1.28M | -42.30%-4.9M | 30.69%-1.41M | ---3.44M | -28.37%-2.03M | ---- |
| Share of profits of associates | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 11.52%-1.31M |
| Earning before tax | -41.91%15.65M | -102.94%-12.22M | -81.60%26.94M | 9,995.78%415.13M | 374.79%146.4M | 99.61%-4.2M | -73.03%30.84M | -545.07%-1.08B | -8.54%114.34M | -70.90%242.71M |
| Tax | -159.79%-1.26M | 98.71%-1.43M | 105.76%2.1M | -287.92%-111.03M | -103.18%-36.42M | -111.84%-28.62M | 40.53%-17.93M | 335.70%241.63M | 23.65%-30.14M | 53.56%-102.52M |
| After-tax profit from continuing operations | -50.43%14.4M | -104.49%-13.66M | -73.59%29.04M | 1,026.69%304.1M | 752.00%109.98M | 96.09%-32.82M | -84.67%12.91M | -698.17%-838.6M | -1.57%84.2M | -77.14%140.19M |
| Earning after tax | -50.43%14.4M | -104.49%-13.66M | -73.59%29.04M | 1,026.69%304.1M | 752.00%109.98M | 96.09%-32.82M | -84.67%12.91M | -698.17%-838.6M | -1.57%84.2M | -77.14%140.19M |
| Minority profit | -400.00%-85K | 677.92%445K | 45.16%-17K | 13.48%-77K | -520.00%-31K | -67.92%-89K | 80.77%-5K | -103.73%-53K | -101.76%-26K | 287.85%1.42M |
| Profit attributable to shareholders | -50.17%14.48M | -104.64%-14.1M | -73.58%29.06M | 1,029.44%304.18M | 751.91%110.01M | 96.10%-32.73M | -84.67%12.91M | -704.26%-838.55M | 0.19%84.22M | -77.40%138.77M |
| Basic earnings per share | -50.00%0.0379 | -105.19%-0.04 | -72.85%0.0758 | 1,062.50%0.77 | 821.45%0.2792 | 95.94%-0.08 | -84.66%0.0303 | -696.97%-1.97 | 0.20%0.1975 | -77.08%0.33 |
| Diluted earnings per share | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.